Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
02/2007
02/08/2007US20070032510 Antagonists to treat neurodegenerative diseases like Parkinson's disease; 2,4,6-trisubstituted pyrimidines; N-(2,6-diphenyl-pyrimidin-4-yl)-benzamide
02/08/2007DE102005035741A1 Quadratsäurederivate Squaric acid derivatives
02/08/2007CA2617103A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007CA2616682A1 Squaric acid derivatives as protein kinase inhibitors
02/07/2007EP1749516A2 Lock and key micelles
02/07/2007EP1749006A2 Heterocyclic compounds and their use as aldosterone synthase inhibitors
02/07/2007EP1749005A1 Tetrahydro-imidazo ¬1,5-a| pyridin derivatives as aldosterone synthase inhibitors
02/07/2007EP1748991A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
02/07/2007EP1704144B1 A method of preparation of the hemi-calcium salt of (e)-7- [4-(4-fluorophenyl)-6-isopropyl-2- [me thyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxy-6-heptenoic acid
02/07/2007EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase
02/07/2007EP1626716B1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
02/07/2007EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same
02/07/2007CN1910160A Method for producing 2-amino-4,6-dichloro-5-formamidopyrimidine
02/07/2007CN1910159A 2,4-diaminopyrimidines and their use for inducing cardiomyogenesis
02/07/2007CN1910141A Diamino alcohols and their use as renin inhibitors
02/07/2007CN1909909A 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
02/07/2007CN1907564A Catalyst for producing ethyoxyl quinoline
02/06/2007US7173130 Detection of transmembrane potentials by optical methods
02/06/2007US7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases
02/06/2007US7173128 Benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole derivatives; polymer and photographic stabilizers
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/06/2007US7173038 Treatment of diseases such as cancer or arthritis
02/06/2007US7173028 Pyrimidine derivatives
02/06/2007US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors
02/06/2007US7173022 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides
02/06/2007US7172749 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
02/01/2007WO2006031806A3 2-thiopyrimidinones as therapeutic agents
02/01/2007WO2006002802A8 Phenyl derivatives comprising an acetylene group
02/01/2007US20070027319 oxidizing an alkyne compound containing pyrimidine and benzene rings with KMnO4 to form 1,2-diketone; reacting 2,4-dichloropyrimidine with (trimethylsilyl)acetylene to form( trimethylsilylethynyl-pyrimidine, reacting intermediate with an amine to form (trimethylsilyl)akyne, deportecting
02/01/2007US20070027318 Quinoline derivatives and quinazoline derivatives
02/01/2007US20070027172 Crystalline pharmaceutical
02/01/2007US20070027156 Crf antagonists and heterobicyclic compounds
02/01/2007US20070027147 Biarylurea derivatives
02/01/2007US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
02/01/2007US20070027131 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
02/01/2007US20070026384 Detection of transmembrane potentials by optical methods
02/01/2007CA2616224A1 10-substituted tetracyclines and methods of use thereof
01/2007
01/31/2007EP1747205A1 Pharmaceutical compositions
01/31/2007EP1747204A1 Tri-substituted ureas as cytokine inhibitors
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1747191A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension
01/31/2007EP1746999A1 4-phenylamino-quinazolin-6-yl-amides
01/31/2007CN1906183A N-acylsulfonamide apoptosis promoters
01/31/2007CN1906178A 喹唑啉衍生物 Quinazoline derivatives
01/31/2007CN1906177A Process for the preparation of pyridopyrimidones
01/31/2007CN1906176A Therapeutic agents II
01/31/2007CN1906175A Crystalline ammonium salts of rosuvastatin
01/31/2007CN1906167A Novel pyridine derivative and pyrimidine derivative (2)
01/31/2007CN1906166A Novel pyridine derivative and pyrimidine derivative (1)
01/31/2007CN1905873A Bicyclic inhibitors of MEK and methods of use thereof
01/31/2007CN1903847A 2-alkylsulfide-5-alkyl-6-(1-cyano aromethyl) substituted uracil kind compound, its preparation method and use
01/31/2007CN1297558C 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds, preparation method thereof and pharmaceutical composition containing them
01/30/2007US7169952 Sulfonation of 1-(5-amino-2,4-dichlorophenyl)-4,5-dihydro-4-difluoromethyl-3-methyl-1,2,4 -triazol-5(1H)-one using mesyl chloride, in the presence of catalysts, to form sulfentrazole used as herbicides or pesticides
01/30/2007US7169951 Quinazoline derivatives and pharmaceutical applications thereof
01/30/2007US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants
01/30/2007US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
01/30/2007US7169802 Fused pyrrolocarbazoles
01/30/2007US7169790 5-substituted 2-aryl-4-pyrimidinones
01/30/2007US7169789 Quinoline derivatives and quinazoline derivatives
01/30/2007US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
01/30/2007US7169781 Such as 2-(2,6-dichlorophenyl)-4-(3-chlorophenyl)-5-(2-methylthiopyrimidin-4-yl)-N H-imidazole as anticarcinogenic agent
01/30/2007US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
01/30/2007US7169325 liquid crystalline compound capable of exhibiting a biaxial liquid crystal phase
01/30/2007CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
01/25/2007WO2007012042A1 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide
01/25/2007WO2007011623A1 Quinazoline derivatives useful in cancer treatment
01/25/2007WO2007011618A1 Quinazoline derivatives useful in cancer treatment
01/25/2007WO2007010222A2 Therapeutic agents
01/25/2007WO2007009715A1 2-cyano-pyrimidines and -triazines as cysteine protease inhibitors
01/25/2007WO2006065277A3 Heterocyclic aspartyl protease inhibitors
01/25/2007US20070021450 Indanylamino uracils and their use as antioxidants and neuroprotectants
01/25/2007US20070021449 Pyrimidine derivatives for the prevention of hiv infection
01/25/2007US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/25/2007US20070021419 2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors
01/25/2007US20070018172 Crystals of phenylalanine derivatives and production methods thereof
01/25/2007CA2615516A1 2-cyano-pyrimidines and -triazines as cysteine protease inhibitors
01/25/2007CA2615380A1 Quinazoline derivatives useful in cancer treatment
01/25/2007CA2615373A1 Quinazoline derivatives useful in cancer treatment
01/25/2007CA2612459A1 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide
01/24/2007EP1746099A1 Mnk1 or Mnk2 inhibitors
01/24/2007EP1746093A1 Process for preparing substituted pyrimidines
01/24/2007EP1745033A2 4,5-disubstituted-2-aryl pyrimidines
01/24/2007EP1174151B1 Therapeutic treatment of eosinophilia using chymase inhibitors as the active ingredient
01/24/2007EP0968206B8 N-heterocyclic derivatives as nos inhibitors
01/24/2007CN1901971A Cyclopropane compounds and pharmaceutical use thereof
01/24/2007CN1900104A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
01/24/2007CN1900096A Process for preparing metal compounds of an azo compound in the presence of seed crystals
01/24/2007CN1900095A Process for preparing metal compounds of an azo compound using pumped circulation
01/24/2007CN1900073A Process for preparing N-phenyl-2-pyrimidyl amine derivative
01/24/2007CN1900066A Process for the preparation of metal compounds of an azo-compound by using a multi-step tempering process
01/24/2007CN1296357C Heteroaryl-substituted aminocyclohexane derivatives
01/24/2007CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
01/23/2007US7166638 Statin derivatives
01/23/2007US7166609 Osteoarthritis; periodontal disease; antiarthritic agents
01/23/2007US7166603 Dihydropyrimidone inhibitors of calcium channel function
01/23/2007US7166599 Trisubstituted pyrimidines
01/23/2007US7166595 3H-Pyrimidin-4-one derivatives; antiproliferative, anticarcinogenic and antiinflammatory agents; hyperplasia, restenosis, cardiac hypertrophy, autoimmune disorders; fungicides
01/23/2007US7166593 Glucocorticoid receptor modulators
01/23/2007CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
01/18/2007WO2007007161A2 Novel bio-active derivatives